| Stage | ABT | % of rev | TMO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $13.0B | 100.00% | $12.1B | 100.00% | ABT ×1.07 |
| Gross profit | $7.4B | 56.75% | $5.1B | 42.28% | ABT +14.5pp |
| Operating income | $1.4B | 10.44% | $2.3B | 18.65% | TMO +8.2pp |
| Pre-tax income | $1.2B | 9.46% | $2.1B | 17.20% | TMO +7.7pp |
| Net income | $920M | 7.07% | $1.7B | 14.23% | TMO +7.2pp |
| Stage | ABT | TMO | Gap · A − B |
|---|---|---|---|
| Revenue | $13.0B100.00% | $12.1B100.00% | ABT ×1.07 |
| Gross profit | 56.75%$7.4B | 42.28%$5.1B | ABT +14.5pp |
| Operating income | 10.44%$1.4B | 18.65%$2.3B | TMO +8.2pp |
| Pre-tax income | 9.46%$1.2B | 17.20%$2.1B | TMO +7.7pp |
| Net income | 7.07%$920M | 14.23%$1.7B | TMO +7.2pp |
No shared counterparties.